Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06089161 · ClinicalTrials.gov registry record · NA

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

A NA study of Sleep Apnea, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
330
Enrollment target
1
Study location

NCT06089161 is a NA study of Sleep Apnea that is actively recruiting participants, run by University of Miami. The registered enrollment target is 330 participants, below the 2,980-participant average among 36 other Sleep Apnea trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06089161, a NA study of Sleep Apnea, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
330 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Conditions Studied

Interventions

  • OTHER Standard of Care
  • BEHAVIORAL Personalized OSA Treatment

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 330 participants
Start Date 2024-03-19
Est. Completion 2028-05-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06089161

The ClinicalTrials.gov registry entry for NCT06089161 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,980-participant average among 36 other Sleep Apnea trials with a reported enrollment target (89% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT06089161 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06089161 about?

NCT06089161 is a clinical study titled "Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks". The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

What is the current status of trial NCT06089161?

This trial is currently recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2024-03-19. Estimated completion is 2028-05-31.

What conditions does trial NCT06089161 study?

This clinical trial studies the following conditions: Sleep Apnea.

What interventions are being tested in trial NCT06089161?

The interventions under investigation include: Standard of Care (OTHER), Personalized OSA Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT06089161?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06089161 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.